Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.
3.
4.

Rifamycin SV exhibits strong anti-inflammatory in vitro activity through pregnane X receptor stimulation and NFκB inhibition.

Rosette C, Agan FJ, Rosette N, Moro L, Mazzetti A, Hassan C, Gerloni M.

Drug Metab Pharmacokinet. 2019 Jun;34(3):172-180. doi: 10.1016/j.dmpk.2019.01.002. Epub 2019 Jan 17.

5.

Cortexolone 17α-Propionate (Clascoterone) is an Androgen Receptor Antagonist in Dermal Papilla Cells In Vitro

Rosette C, Rosette N, Mazzetti A, Moro L, Gerloni M.

J Drugs Dermatol. 2019 Feb 1;18(2):197-201.

PMID:
30811143
6.

Anti-inflammatory and immunomodulatory activities of rifamycin SV.

Rosette C, Buendia-Laysa F Jr, Patkar S, Moro L, Celasco G, Bozzella R, Ajani M, Gerloni M.

Int J Antimicrob Agents. 2013 Aug;42(2):182-6. doi: 10.1016/j.ijantimicag.2013.04.020. Epub 2013 Jun 5.

PMID:
23756321
7.

TLR9-independent activation of B lymphocytes by bacterial DNA.

Cortez-Gonzalez X, Pellicciotta I, Gerloni M, Wheeler MC, Castiglioni P, Lenert P, Zanetti M.

DNA Cell Biol. 2006 May;25(5):253-61.

PMID:
16716115
8.

The cooperation between two CD4 T cells induces tumor protective immunity in MUC.1 transgenic mice.

Gerloni M, Castiglioni P, Zanetti M.

J Immunol. 2005 Nov 15;175(10):6551-9.

9.

In utero DNA immunisation. Immunity over tolerance in fetal life.

Rizzi M, Gerloni M, Srivastava AS, Wheeler MC, Schuler K, Carrier E, Zanetti M.

Vaccine. 2005 Jul 21;23(33):4273-82.

PMID:
16005117
10.

CD4 T cells in tumor immunity.

Gerloni M, Zanetti M.

Springer Semin Immunopathol. 2005 Jun;27(1):37-48. Epub 2005 Mar 15. Review.

PMID:
15965712
11.

CD8 T cell priming by B lymphocytes is CD4 help dependent.

Castiglioni P, Gerloni M, Cortez-Gonzalez X, Zanetti M.

Eur J Immunol. 2005 May;35(5):1360-70.

12.
13.

B lymphocytes as antigen-presenting cell-based genetic vaccines.

Zanetti M, Castiglioni P, Rizzi M, Wheeler M, Gerloni M.

Immunol Rev. 2004 Jun;199:264-78. Review.

PMID:
15233740
14.

T cell immunity using transgenic B lymphocytes.

Gerloni M, Rizzi M, Castiglioni P, Zanetti M.

Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3892-7. Epub 2004 Mar 2.

15.

Spontaneous transgenesis of human B lymphocytes.

Filaci G, Gerloni M, Rizzi M, Castiglioni P, Chang HD, Wheeler MC, Fiocca R, Zanetti M.

Gene Ther. 2004 Jan;11(1):42-51.

PMID:
14681696
16.

The role of relB in regulating the adaptive immune response.

Zanetti M, Castiglioni P, Schoenberger S, Gerloni M.

Ann N Y Acad Sci. 2003 Apr;987:249-57. Review.

PMID:
12727647
17.

Role of T cell help and endoplasmic reticulum targeting in protective CTL response against influenza virus.

Langlade-Demoyen P, Garcia-Pons F, Castiglioni P, Garcia Z, Cardinaud S, Xiong S, Gerloni M, Zanetti M.

Eur J Immunol. 2003 Mar;33(3):720-8.

18.

CD4 T cell priming in dendritic cell-deficient mice.

Castiglioni P, Lu C, Lo D, Croft M, Langlade-Demoyen P, Zanetti M, Gerloni M.

Int Immunol. 2003 Jan;15(1):127-36.

PMID:
12502733
19.

Cross-priming is under control of the relB gene.

Castiglioni P, Janssen EM, Prilliman KR, Gerloni M, Schoenberger S, Zanetti M.

Scand J Immunol. 2002 Sep;56(3):219-23.

20.

Studies on CD4 T cell immunity using somatic transgene immunization.

Gerloni M, Zanetti M.

Int Rev Immunol. 2001 Oct;20(5):613-25. Review.

PMID:
11890615
21.

Circumvention of MHC class II restriction by genetic immunization.

Schuler K, Lu C, Chang HD, Croft M, Zanetti M, Gerloni M.

Vaccine. 2001 Nov 12;20(3-4):630-4.

PMID:
11672931
22.

Functional cooperation between T helper cell determinants.

Gerloni M, Xiong S, Mukerjee S, Schoenberger SP, Croft M, Zanetti M.

Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13269-74.

23.
24.

A transphyletic anti-infectious control strategy based on the killer phenomenon.

Conti S, Magliani W, Gerloni M, Salati A, Dieci E, Arseni S, Fisicaro P, Polonelli L.

FEMS Immunol Med Microbiol. 1998 Sep;22(1-2):151-61. Review.

26.

Durable immunity and immunologic memory to a parasite antigen induced by somatic transgene immunization.

Gerloni M, Xiong S, Zanetti M.

Vaccine. 1998 Jan-Feb;16(2-3):293-7.

PMID:
9607045
27.
28.

Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodies.

Conti S, Fanti F, Magliani W, Gerloni M, Bertolotti D, Salati A, Cassone A, Polonelli L.

J Infect Dis. 1998 Mar;177(3):807-11.

PMID:
9498471
29.

Engineering vaccines with heterologous B and T cell epitopes using immunoglobulin genes.

Xiong S, Gerloni M, Zanetti M.

Nat Biotechnol. 1997 Sep;15(9):882-6.

PMID:
9306404
30.

Immunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization.

Gerloni M, Baliou WR, Billetta R, Zanetti M.

Nat Biotechnol. 1997 Sep;15(9):876-81.

PMID:
9306403
31.

Yeast killer systems.

Magliani W, Conti S, Gerloni M, Bertolotti D, Polonelli L.

Clin Microbiol Rev. 1997 Jul;10(3):369-400. Review.

32.

In vivo role of B lymphocytes in somatic transgene immunization.

Xiong S, Gerloni M, Zanetti M.

Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6352-7.

33.

Somatic transgene immunization with DNA encoding an immunoglobulin heavy chain.

Gerloni M, Billetta R, Xiong S, Zanetti M.

DNA Cell Biol. 1997 May;16(5):611-25.

PMID:
9174166
34.

Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies.

Polonelli L, Séguy N, Conti S, Gerloni M, Bertolotti D, Cantelli C, Magliani W, Cailliez JC.

Clin Diagn Lab Immunol. 1997 Mar;4(2):142-6.

35.

Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity.

Magliani W, Conti S, de Bernardis F, Gerloni M, Bertolotti D, Mozzoni P, Cassone A, Polonelli L.

Nat Biotechnol. 1997 Feb;15(2):155-8.

PMID:
9035141
36.

Candida albicans stress mannoprotein, SMP200, enhances tumour necrosis factor secretion in the murine macrophage cell line ANA-1.

Pitzurra L, Polonelli L, Cantelli C, Gerloni M, Ponton J, Bikandi J, Blasi E.

J Med Vet Mycol. 1996 Jun-Jul;34(3):219-22.

PMID:
8803805
37.

Human natural yeast killer toxin-like candidacidal antibodies.

Polonelli L, De Bernadis F, Conti S, Boccanera M, Magliani W, Gerloni M, Cantelli C, Cassone A.

J Immunol. 1996 Mar 1;156(5):1880-5.

PMID:
8596040
38.

Killer factor interference in mixed opportunistic yeast cultures.

Conti S, Cantelli C, Gerloni M, Fisicaro P, Magliani W, Bertolotti D, Mozzoni P, Sullivan D, Coleman D, Polonelli L.

Mycopathologia. 1996;135(1):1-8.

PMID:
9008877
39.

Candida albicans stress mannoproteins expression in superficial and systemic candidiasis. Stress mannoproteins in Candida albicans.

Pontón J, Hernando FL, Moragues MD, Barea PL, Gerloni M, Conti S, Fisicaro P, Cantelli C, Polonelli L.

Mycopathologia. 1996;133(2):89-94.

PMID:
8751828
40.

Use of yeast killer system to identify species of the Nocardia asteroides complex.

Provost F, Polonelli L, Conti S, Fisicaro P, Gerloni M, Boiron P.

J Clin Microbiol. 1995 Jan;33(1):8-10.

41.

Killer toxin secretion through the cell wall of the yeast Pichia anomala.

Cailliez JC, Cantelli C, Séguy N, Conti S, Gerloni M, Morace G, Polonelli L.

Mycopathologia. 1994 Jun;126(3):173-7.

PMID:
7935732
42.

Heat-shock mannoproteins as targets of secretory IgA in Candida albicans.

Polonelli L, Gerloni M, Conti S, Fisicaro P, Cantelli C, Portincasa P, Almondo F, Barea PL, Hernando FL, Ponton J.

J Infect Dis. 1994 Jun;169(6):1401-5.

PMID:
7515089
43.

Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies.

Polonelli L, De Bernardis F, Conti S, Boccanera M, Gerloni M, Morace G, Magliani W, Chezzi C, Cassone A.

J Immunol. 1994 Mar 15;152(6):3175-82.

PMID:
8144911
44.

New strategies in vaccination against fungal infections.

Polonelli L, Poulain D, Cole GT, Conti S, Elad D, Gerloni M, Kirkland T, Matthews R, Segal E, Wyckoff E.

J Med Vet Mycol. 1994;32 Suppl 1:105-12. Review. No abstract available.

PMID:
7536837
45.

Idiotypic vaccination: immunoprotection mediated by anti-idiotypic antibodies with antibiotic activity.

Polonelli L, Lorenzini R, De Bernardis F, Gerloni M, Conti S, Morace G, Magliani W, Chezzi C.

Scand J Immunol. 1993 Jan;37(1):105-10.

PMID:
8418467
46.

Genomic studies on killer yeasts belonging to the genus Pichia.

Morace G, Cattani P, Manzara S, Conti S, Gerloni M, Sanguinetti M, Posteraro B, Polonelli L.

Antonie Van Leeuwenhoek. 1992 Oct;62(3):215-23.

PMID:
1358028
47.

Anaerobic yeast killer systems.

Polonelli L, Menozzi MG, Campani L, Gerloni M, Conti S, Morace G, Chezzi C.

Eur J Epidemiol. 1992 May;8(3):471-6.

PMID:
1397211
48.

Killer system interactions.

Polonelli L, Morace G, Conti S, Gerloni M, Magliani W, Chezzi C.

Curr Top Med Mycol. 1992;4:137-57. Review. No abstract available.

PMID:
1732065
49.

Ultrastructural immunodetection of a Pichia anomala killer toxin: a preliminary study.

Cailliez JC, Gerloni M, Morace G, Conti S, Cantelli C, Polonelli L.

Biol Cell. 1992;75(1):19-23.

PMID:
1381254
50.

Improved immunoblotting for the detection and quantitative analysis of antibodies to human immunodeficiency virus.

Portincasa P, Conti G, Gerloni M, Chezzi C.

Eur J Epidemiol. 1991 Nov;7(6):705-8.

PMID:
1783068

Supplemental Content

Loading ...
Support Center